In a note Friday, Wedbush projected that tech stocks are set for a strong second half of 2025, buoyed by a “very strong 2Q ...

Investing.com - U.S. consumer sentiment touched its highest point in five months in July, but remains well below its historical average, as concerns remain around the impact of sw ...

Jefferies has added five new stocks to its EMEA Franchise Picks list, selecting Assa Abloy (ST: ASSAb), British American ...

The European Central Bank is due to unveil its next policy decision on July 24, with investors widely anticipating that it ...

Medvedev, who currently serves as deputy chairman of Russia’s Security Council, made these remarks after the EU approved its 18th package of sanctions against Russia over the war in Ukraine. The new ...

Investing.com -- BMO Capital Markets upgraded Chipotle Mexican Grill (NYSE: CMG) to Outperform and raised its price target to ...

The Dallas-based bank reported adjusted earnings per share of $0.56 for the quarter ended June 30, 2025, surpassing the analyst consensus of $0.54. Revenue totaled $109.83 million, just below the ...

Pop Culture Group Co Ltd (NASDAQ: CPOP) stock surged 25% after the Chinese cultural content company announced plans to enter the cryptocurrency sector with initia ...

FX liquidity will likely be sparse given that Monday is a public holiday in Japan, and the JGB and stock markets will also be ...

Investing.com -- Donald Trump’s return to the White House raises fresh questions about whether the U.S. can avoid a renewed ...

Investing.com -- Mesoblast Ltd (NASDAQ: MESO) stock surged 25% after the company reported its first quarter of sales for its ...

According to the company, Telomir-1 may reactivate the body’s natural tumor suppressor system by restoring STAT1 activity, potentially allowing immune cells to recognize and eliminate cancer cells.